Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Infusion vs Traditional Agents in Refractory Status Epilepticus
NCT03115489Phase 3Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- May 2017
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in status epilepticus (SE), sponsored by University of Alabama at Birmingham. Planned start May 2017; status: withdrawn.
02
Drugs
ketamine
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT03115489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03115489.